Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Dividends payables (2016 - 2018)

Quarterly results put Dividends payables at $38000.0 for Q4 2018, changed 0.0% from a year ago — trailing twelve months through Dec 2018 was $38000.0 (changed 0.0% YoY), and the annual figure for FY2018 was $38000.0, changed 0.0%.

Armata Pharmaceuticals has reported Dividends payables over the past 4 years, most recently at $38000.0 for Q4 2018.

  • Dividends payables reached $38000.0 in Q4 2018 per ARMP's latest filing, roughly flat from $38000.0 in the prior quarter.
  • Across five years, Dividends payables topped out at $970000.0 in Q2 2016 and bottomed at $38000.0 in Q4 2016.
  • Median Dividends payables over the past 4 years was $84500.0 (2015), compared with a mean of $282166.7.
  • The largest annual shift saw Dividends payables skyrocketed 640.46% in 2016 before it plummeted 96.08% in 2017.
  • Over 4 years, Dividends payables stood at $368000.0 in 2015, then tumbled by 89.67% to $38000.0 in 2016, then changed by 0.0% to $38000.0 in 2017, then changed by 0.0% to $38000.0 in 2018.
  • Business Quant data shows Dividends payables for ARMP at $38000.0 in Q4 2018, $38000.0 in Q4 2017, and $38000.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 38,000.00
Dec 31, 2017 38,000.00
Sep 30, 2017 38,000.00
Jun 30, 2017 38,000.00
Mar 31, 2017 38,000.00
Dec 31, 2016 38,000.00
Sep 30, 2016 953,000.00
Jun 30, 2016 970,000.00